StoxLaurus Labs vs Apollo Hospitals Enterprise: share price & financials comparison
NSE: LAURUSLABS vs APOLLOHOSP · Healthcare · as of 06 Nov 2026
Both prices rebased to 100 at the start of the selected period.
Laurus Labs vs Apollo Hospitals Enterprise at a glance
Laurus Labs (LAURUSLABS) has a market capitalisation of ₹1,26,430 Cr, against ₹1,21,453 Cr for Apollo Hospitals Enterprise (APOLLOHOSP). Over the past year Laurus Labs has returned +143.3%, compared with +7.5% for Apollo Hospitals Enterprise. On valuation, Apollo Hospitals Enterprise trades at a lower P/E of 54.2 versus 94.4. Laurus Labs earns a higher return on equity (22.1% vs 21.1%). Laurus Labs comes out ahead on profitability, growth, financial health, momentum and technicals. Apollo Hospitals Enterprise comes out ahead on size and valuation. Across the scored metrics below, Laurus Labs leads on 12 and Apollo Hospitals Enterprise on 5. On StoxGud's 10-point checklist, Laurus Labs scores 8/10 and Apollo Hospitals Enterprise scores 8/10.
| Metric | Laurus Labs | Apollo Hospitals Enterprise |
|---|---|---|
| Size | ||
| Market cap | ₹1,26,430 Cr | ₹1,21,453 Cr |
| Revenue (latest FY) | ₹6,813 Cr | ₹25,228 Cr |
| Net profit (latest FY) | ₹889 Cr | ₹1,942 Cr |
| Valuation | ||
| P/E | 94.4 | 54.2 |
| P/B | 20.86 | 11.45 |
| Dividend yield | 0.07% | 0.24% |
| Profitability | ||
| Return on equity | 22.1% | 21.1% |
| Net profit margin | 17.1% | 8.1% |
| Operating margin | 30.4% | 15.4% |
| Growth | ||
| Revenue growth (YoY) | +33.4% | +20.8% |
| Net profit growth (YoY) | +126.4% | +32.0% |
| Revenue CAGR (multi-year) | +7.2% | +19.0% |
| Financial health | ||
| Debt to equity | 0.41 | 0.53 |
| Momentum | ||
| 1-month return | +14.0% | +6.7% |
| 1-year return | +143.3% | +7.5% |
| 3-year CAGR | +84.5% | +17.8% |
| 5-year CAGR | +36.4% | +13.9% |
| 10-year CAGR | — | +20.8% |
| Distance from 52W high | -2.7% | -6.9% |
| Technicals | ||
| RSI (14) | 71 | 66 |
| Price vs 200-day avg | +58.0% | +3.9% |
Highlighted cells lead on that metric. Market cap, revenue and RSI are shown for context and not scored.
10-point checklist side by side
| Check | Laurus Labs | Apollo Hospitals Enterprise |
|---|---|---|
| Price above 50-day average | ✓ | ✓ |
| Price above 200-day average | ✓ | ✓ |
| 50-day average above 200-day (uptrend) | ✓ | ✓ |
| RSI in healthy 40–70 zone | ✗ | ✓ |
| Positive 1-year return | ✓ | ✓ |
| Return on equity above 15% | ✓ | ✓ |
| Debt to equity below 1 | ✓ | ✓ |
| Revenue growing year on year | ✓ | ✓ |
| Net profit margin above 10% | ✓ | ✗ |
| P/E below industry median | ✗ | ✗ |
| Score | 8/10 | 8/10 |
A rules-based screen for education only — not a buy or sell recommendation.
FAQs
Which is bigger, Laurus Labs or Apollo Hospitals Enterprise?
Laurus Labs has a market cap of ₹1,26,430 Cr and Apollo Hospitals Enterprise has a market cap of ₹1,21,453 Cr as of 06 Nov 2026.
Which has a lower P/E, Laurus Labs or Apollo Hospitals Enterprise?
Apollo Hospitals Enterprise has the lower P/E: Laurus Labs trades at 94.4 and Apollo Hospitals Enterprise at 54.2.
Which gave better returns in the last year, Laurus Labs or Apollo Hospitals Enterprise?
Laurus Labs did better: Laurus Labs returned +143.3% and Apollo Hospitals Enterprise returned +7.5% over one year.
Is Laurus Labs or Apollo Hospitals Enterprise a better buy?
StoxGud does not give buy or sell recommendations. On our rules-based checklist Laurus Labs scores 8/10 and Apollo Hospitals Enterprise scores 8/10; compare valuation, profitability, growth and momentum above and consult a SEBI-registered adviser.